Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Graillon

Showing results (71-80 of 102) with videos related to

Pageof 11
Sort By:
Endocrine-Related Cancer|June 9, 2016
In vitro impact of pegvisomant on growth hormone-secreting pituitary adenoma cellsThomas Cuny, Caroline Zeiller, Martin Bidlingmaier, et al.
Neuro-Oncology|September 10, 2024
Brain tumoroids: Treatment prediction and drug development for brain tumors with fast, reproducible, and easy-to-use personalized modelsAurélie Soubéran, Carine Jiguet-Jiglaire, Soline Toutain, et al.
Clinical Endocrinology|February 10, 2015
Postoperative follow-up of Cushing's disease using cortisol, desmopressin and coupled dexamethasone-desmopressin tests: a head-to-head comparisonPauline Le Marc'hadour, Marie Muller, Frederique Albarel, et al.
The Journal of Clinical Endocrinology and Metabolism|April 13, 2026
3D volume growth rate may open new perspectives for the classification of aggressive pituitary adenomasThomas Graillon, Emeline Tabouret, Romain Appay, et al.
Journal of Neuro-Oncology|January 7, 2022
Adult H3K27M mutated thalamic glioma patients display a better prognosis than unmutated patientsStéphan Grimaldi, Vincent Harlay, Romain Appay, et al.
European Radiology|June 5, 2024
Comparison of scales for the evaluation of aneurysmal subarachnoid haemorrhage: a retrospective cohort studyDavid Couret, Salah Boussen, Dan Cardoso, et al.
Journal of Neuro-Oncology|May 28, 2015
Combined treatment by octreotide and everolimus: Octreotide enhances inhibitory effect of everolimus in aggressive meningiomasThomas Graillon, Céline Defilles, Amira Mohamed, et al.
Pituitary|January 12, 2021
Characterization of the ability of a, second-generation SST-DA chimeric molecule, TBR-065, to suppress GH secretion from human GH-secreting adenoma cellsThomas Cuny, Thomas Graillon, Célines Defilles, et al.
Neuro-Oncology|February 8, 2021
Role of 3D volume growth rate for drug activity evaluation in meningioma clinical trials: the example of the CEVOREM studyThomas Graillon, Loic Ferrer, Jason Siffre, et al.
Anticancer Research|February 4, 2019
Leptomeningeal Gliomatosis: A Single Institution Study of 31 PatientsDidier Autran, Maryline Barrie, Mona Matta, et al.
Pageof 11

Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Endocrine-Related Cancer|June 9, 2016
In vitro impact of pegvisomant on growth hormone-secreting pituitary adenoma cellsThomas Cuny, Caroline Zeiller, Martin Bidlingmaier, et al.
Neuro-Oncology|September 10, 2024
Brain tumoroids: Treatment prediction and drug development for brain tumors with fast, reproducible, and easy-to-use personalized modelsAurélie Soubéran, Carine Jiguet-Jiglaire, Soline Toutain, et al.
Clinical Endocrinology|February 10, 2015
Postoperative follow-up of Cushing's disease using cortisol, desmopressin and coupled dexamethasone-desmopressin tests: a head-to-head comparisonPauline Le Marc'hadour, Marie Muller, Frederique Albarel, et al.
The Journal of Clinical Endocrinology and Metabolism|April 13, 2026
3D volume growth rate may open new perspectives for the classification of aggressive pituitary adenomasThomas Graillon, Emeline Tabouret, Romain Appay, et al.
Journal of Neuro-Oncology|January 7, 2022
Adult H3K27M mutated thalamic glioma patients display a better prognosis than unmutated patientsStéphan Grimaldi, Vincent Harlay, Romain Appay, et al.
European Radiology|June 5, 2024
Comparison of scales for the evaluation of aneurysmal subarachnoid haemorrhage: a retrospective cohort studyDavid Couret, Salah Boussen, Dan Cardoso, et al.
Journal of Neuro-Oncology|May 28, 2015
Combined treatment by octreotide and everolimus: Octreotide enhances inhibitory effect of everolimus in aggressive meningiomasThomas Graillon, Céline Defilles, Amira Mohamed, et al.
Pituitary|January 12, 2021
Characterization of the ability of a, second-generation SST-DA chimeric molecule, TBR-065, to suppress GH secretion from human GH-secreting adenoma cellsThomas Cuny, Thomas Graillon, Célines Defilles, et al.
Neuro-Oncology|February 8, 2021
Role of 3D volume growth rate for drug activity evaluation in meningioma clinical trials: the example of the CEVOREM studyThomas Graillon, Loic Ferrer, Jason Siffre, et al.
Anticancer Research|February 4, 2019
Leptomeningeal Gliomatosis: A Single Institution Study of 31 PatientsDidier Autran, Maryline Barrie, Mona Matta, et al.
Pageof 11